Stock Market News3 days AstraZeneca boosts China presence with FibroGen’s anemia drug in $160 million deal Investing.com
AstraZeneca boosts China presence with FibroGen’s anemia drug in $160 million deal.
XAstraZeneca boosts China presence with FibroGen’s anemia drug in $160 million deal.
X